Development of bimetallic titanocene-ruthenium-arene complexes as anticancer agents: relationships between structural and biological properties.
about
Design, synthesis and characterisation of new chimeric ruthenium(II)-gold(I) complexes as improved cytotoxic agents.Organometallic Titanocene-Gold Compounds as Potential Chemotherapeutics in Renal Cancer. Study of their Protein Kinase Inhibitory Properties.Titanocene-phosphine derivatives as precursors to cytotoxic heterometallic TiAu2 and TiM (M = Pd, Pt) compounds. Studies of their interactions with DNALuminescent di- and polynuclear organometallic gold(I)-metal (Au2, {Au2Ag}n and {Au2Cu}n) compounds containing bidentate phosphanes as active antimicrobial agents.Organometallic Palladium Complexes with a Water-Soluble Iminophosphorane Ligand as Potential Anticancer Agents.Titanocene-Gold Complexes Containing N-Heterocyclic Carbene Ligands Inhibit Growth of Prostate, Renal, and Colon Cancers in Vitro.Novel enantiopure cyclopentadienyl Ti(IV) oximato compounds as potential anticancer agents.Potential anticancer heterometallic Fe-Au and Fe-Pd agents: initial mechanistic insights.Targeted and multifunctional arene ruthenium chemotherapeutics.Anti-cancer palladium complexes: a focus on PdX2L2, palladacycles and related complexes.Gold(I) NHC-based homo- and heterobimetallic complexes: synthesis, characterization and evaluation as potential anticancer agents.A potential rhodium cancer therapy: studies of a cytotoxic organorhodium(I) complex that binds DNA.Cytotoxic gold compounds: synthesis, biological characterization and investigation of their inhibition properties of the zinc finger protein PARP-1.Designing organometallic compounds for catalysis and therapy.Coordination-Driven Self-Assembly and Anticancer Potency Studies of Ruthenium-Cobalt-Based Heterometallic Rectangles.Heterodinuclear Pt(iv)-Ru(ii) anticancer prodrugs to combat both drug resistance and tumor metastasis.Transfer Hydrogenation and Antiproliferative Activity of Tethered Half-Sandwich Organoruthenium Catalysts.Exploring the Ruthenium-Ligands Bond and Their Relative Properties at Different Computational Methods
P2860
Q30380707-09220348-B549-4E1F-BED9-F6DEC9FFBCB7Q34576153-9DE40D2D-7ABF-48B3-802E-E4925B0067A1Q35489393-DE7D1CB4-CB1B-4D7E-843B-6E85CB6946A6Q36021556-5B028EAC-BBE4-4941-9F50-9BBEBAA534CAQ36304307-5240FF2E-3B42-4678-8698-97B9C9814A79Q36890078-304E320D-F192-4E99-B5AC-14E69C441A31Q36942237-D796A290-E853-4DBA-860C-892F70D9574AQ37432620-ED1E3446-A839-46E5-BC81-B97B10C5AEAEQ37920741-221F3C64-E89A-4487-BBAB-56856B26FA07Q38203819-ECB20D1C-2F91-4CB4-B272-E8E741FBC700Q38850175-9CA6FB9C-B675-4461-8839-CEC69A4DCD34Q39173607-8EAD68DE-F764-4F84-B9AD-89A03D17E018Q39404168-64A1FA67-6019-4C2C-AE16-38CD9CBFBC1DQ48007506-0A6CF70D-31F8-42EB-87BC-667A23B8797EQ48053815-740C4C04-D0EA-462E-8B13-C25BD647B0D1Q53774494-82D0B9B4-093E-49D6-8978-E31B4B958650Q54978767-44B54E9A-2658-47ED-BCF7-0C78C825A680Q59125496-942CBAF7-831B-41F0-A6DB-E63C40B50208
P2860
Development of bimetallic titanocene-ruthenium-arene complexes as anticancer agents: relationships between structural and biological properties.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Development of bimetallic tita ...... ral and biological properties.
@en
Development of bimetallic tita ...... ral and biological properties.
@nl
type
label
Development of bimetallic tita ...... ral and biological properties.
@en
Development of bimetallic tita ...... ral and biological properties.
@nl
prefLabel
Development of bimetallic tita ...... ral and biological properties.
@en
Development of bimetallic tita ...... ral and biological properties.
@nl
P2093
P50
P356
P1476
Development of bimetallic tita ...... ural and biological properties
@en
P2093
Alexandre Massard
Fabio Edafe
Frédéric Pelletier
Michel Picquet
Philippe Richard
Stéphanie Toulot
Virginie Comte
P304
P356
10.1021/JM1004804
P407
P577
2010-10-01T00:00:00Z